Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Comparing Intensity Modulated Proton Therapy to Volume Modulated Arc Therapy for the Treatment of Endometrial and Cervical Cancer

Trial Status: active

This clinical trial compares the side effects of intensity modulated proton therapy (IMPT) to volume modulated arc therapy (VMAT) for the treatment of patients with endometrial or cervical cancer. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. Both IMPT and VMAT are types of radiation therapy; however, IMPT uses proton beams and VMAT uses photon beams. Radiation therapy for endometrial and cervical cancer, such as IMPT and VMAT, comes with a risk of side effects which can impact patient quality of life. Both IMPT and VMAT are associated with improving delivery of radiation therapy and sparing organs surrounding the cancer; however, a need remains to learn more about the side effects experienced from each approach. Researchers hope that by comparing the side effects of IMPT to VMAT they will be able to identify which approach may be safer and/or more tolerable in treating patients with endometrial or cervical cancer.